Back | Next |
home / stock / mnkd / mnkd message board
Subject | By | Source | When |
---|---|---|---|
Lets Go! | Profit | investorshub | 05/28/2021 11:27:05 PM |
Easier to read this way... | chrismiss_everyday | investorshub | 05/20/2021 9:33:21 PM |
Tired of Pricks? | chrismiss_everyday | investorshub | 05/14/2021 8:14:17 PM |
MC- And we're looking forward to hopefully having | chrismiss_everyday | investorshub | 05/13/2021 11:25:21 PM |
Great report an the stock is red! This | harry crumb | investorshub | 05/12/2021 8:45:15 PM |
I wonder if Tyvaso would help in post | bakersson | investorshub | 04/03/2021 3:27:21 PM |
April 01 press release: | Quaaflac | investorshub | 04/02/2021 1:26:58 PM |
How is Afrezza doing? Have they grown prescriptions | SidVicious | investorshub | 03/10/2021 4:56:04 PM |
Buying time is here. | chrismiss_everyday | investorshub | 03/10/2021 4:40:12 PM |
CEO acquiring more stock...hmmm | Quaaflac | investorshub | 03/09/2021 8:04:34 PM |
I don't mind sale prices... | chrismiss_everyday | investorshub | 03/08/2021 8:03:56 PM |
Typical day trader reaction, this will rebound an | harry crumb | investorshub | 03/02/2021 1:45:22 PM |
All bio company's do this, typical to have | harry crumb | investorshub | 03/02/2021 1:43:46 PM |
Wow - typical Mannkind. | joro44 | investorshub | 03/01/2021 9:06:13 PM |
More dilution - here it comes. | joro44 | investorshub | 03/01/2021 1:19:16 PM |
Lets not give Clay that much credit the | Profit | investorshub | 02/25/2021 8:25:53 AM |
He stopped the momentum for two days but | Hypi | investorshub | 02/25/2021 2:41:34 AM |
whytestocks: $MNKD News Article - Vertice launches THYQUIDITY(TM) (levothyroxine sodium) Oral Soluti | whytestocks | investorshangout | 02/24/2021 4:35:53 PM |
Looks like Clay is calling in the 2nd | Profit | investorshub | 02/20/2021 1:51:58 AM |
* * $MNKD Video Chart 02-19-2021 * * | ClayTrader | investorshub | 02/19/2021 11:00:39 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 10:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Study proves inhaled insulin is as effective as usual care (primarily automated insulin delivery pumps or multiple daily injections) for adults living with T1D meeting the primary endpoint Patients utilizing inhaled insulin reached target A1c (less than 7%) 30% of the time compared to 17%...
17-week endpoint results comparing Afrezza ® head-to-head with multiple daily injections (MDI) and insulin pumps INHALE-3 Study Protocol Chair Dr. Irl. B. Hirsh joined by investigational team to deliver presentation moderated by Jaeb Center founder Dr. Roy W. Beck ...